Chemoinformaics analysis of 2-Methoxybenzaldehyde
Molecular Weight | 136.15 | nRot | 2 |
Heavy Atom Molecular Weight | 128.086 | nRig | 7 |
Exact Molecular Weight | 136.052 | nRing | 1 |
Solubility: LogS | -1.953 | nHRing | 0 |
Solubility: LogP | 1.726 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 20.2983 |
nHD | 0 | BPOL | 10.6297 |
QED | 0.576 |
Synth | 1.576 |
Natural Product Likeliness | -0.172 |
NR-PPAR-gamma | 0.024 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.013 |
HIA | 0.009 |
CACO-2 | -4.363 |
MDCK | 0.0000249 |
BBB | 0.984 |
PPB | 0.745822 |
VDSS | 0.997 |
FU | 0.218897 |
CYP1A2-inh | 0.915 |
CYP1A2-sub | 0.89 |
CYP2c19-inh | 0.406 |
CYP2c19-sub | 0.809 |
CYP2c9-inh | 0.057 |
CYP2c9-sub | 0.814 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.79 |
CYP3a4-inh | 0.024 |
CYP3a4-sub | 0.288 |
CL | 6.647 |
T12 | 0.795 |
hERG | 0.061 |
Ames | 0.152 |
ROA | 0.022 |
SkinSen | 0.411 |
Carcinogencity | 0.631 |
EI | 0.995 |
Respiratory | 0.968 |
NR-Aromatase | 0.013 |
Antiviral | No |
Prediction | 0.886946 |